Leaders in regulatory excellence
Our regulatory specialists take active roles in shaping key industry bodies including the European and United States Pharmacopoeia, EXCiPACT™ and IPEC. They represent our dedicated Pharma Manufacturing sites and act as the link between the Pharma business, the regional manufacturing sites and regional sales teams. Extensive experience in the submission and progression of new monographs and teams experience in supporting the use of novel and innovative pharmaceutical products in customer formulations had a particular role to play in the recent success of our business.
Miquel Mir
Global Quality and Regulatory Manager – Pharma excipients
Miquel has a PhD in Organic Chemistry and joined Croda (Uniqema) 25 years ago as the European Technical Service Manager for Pharma. Since then, he has worked in different positions in the areas of Quality and GMP’s, Regulatory Affairs and Product Development. He is currently a member of the Ph. Eur. Expert Group 13H (fatty acids and derivatives) and of the USP Excipient Expert Volunteers Committee and an active member of several committees and task forces in IPEC Europe. In his current position he is working on assisting customers, the global sales force and manufacturing site quality teams regarding pharmaceutical excipient regulatory matters. His work contributes to the development of the business for pharmaceutical excipients by helping to meet the high expectations of the industry on the quality and regulatory requirements for excipients.
Helen Albans
Regulatory Submissions Manager, Croda Pharma
Helen Albans is Regulatory Submissions Manager for Croda Pharma based in the UK. She has years of experience in product development, GMP manufacturing of Active Pharmaceutical Ingredients and Excipients, and regulatory affairs. Her extensive regulatory knowledge and experience includes authoring and submitting drug master files, regulatory lifecycle management, strategy for change implementation, and interacting with clients and Health Authorities.
Peter Bonde Jørgensen
Senior Regulatory Affairs Specialist - Vaccine Adjuvants
Peter has a Master’s degree in Biology-Biotechnology from the University of Copenhagen and more than 14 years of experience at Croda. He specialises in vaccine adjuvants, including aseptically manufactured sterile products and investigational products, and is regularly consulted as a subject matter expert across Croda’s global adjuvant portfolio. His role bridges R&D, manufacturing, Quality, Sales and external regulatory partners, bringing product and site knowledge into customer projects, regulatory documentation, submissions, change assessments and Drug Master File lifecycle management.
In this capacity, Peter provides regulatory direction on both development-stage and commercial vaccine adjuvants, helping align scientific, GMP and market expectations into clear, practical and submission-ready positions. His work contributes to the development of Croda’s vaccine adjuvant business by strengthening customer-facing regulatory support and ensuring consistent regulatory input across human and veterinary vaccine development.
In this capacity, Peter provides regulatory direction on both development-stage and commercial vaccine adjuvants, helping align scientific, GMP and market expectations into clear, practical and submission-ready positions. His work contributes to the development of Croda’s vaccine adjuvant business by strengthening customer-facing regulatory support and ensuring consistent regulatory input across human and veterinary vaccine development.
Ella Chen
Product Safety Regulatory Affairs Manager - China
Ella Chen is the Product Safety Regulatory Affairs Manager in China. She is a regulatory affairs expert with years experience of regulatory affairs managing. She possesses an extensive knowledge on drug master files, toxicology, and chemical testing. As a member of IPEC China, she participated various discussions with authority on ChP development.
Hui Xin Lim
Head of Regional Product Safety Regulatory Affairs (Asia)
Hui Xin serves as the Head of Regional Product Safety & Regulatory Affairs (Asia) and is based in Singapore. She brings extensive experience in regulatory affairs management, with a strong focus on ensuring compliance and product safety across diverse markets. In her current role, Hui Xin collaborates closely with regional sales teams and manufacturing site quality functions to provide expert guidance on pharmaceutical excipient regulatory requirements. She plays a key role in supporting regulatory strategy, addressing compliance challenges, and facilitating alignment with evolving regional and global standards. Her work is instrumental in enabling market access, maintaining product quality, and ensuring adherence to regulatory frameworks across Asia.
Quality
The pharmaceutical industry is highly regulated, and products of high and consistent quality are essential. When manufactured ingredients are used in drug or vaccines formulations, risk of quality failures must be minimised, and ultimately patient safety ensured.
EXCiPACT
Our leading global excipient manufacturing sites have completed the audit requirements of EXCiPACT and we are the first excipient manufacturer to achieve EXCiPACT certification across multiple production facilities.
Adjuvant GMP certificates
View and download the certificates from the two sites of Croda Denmark (Elsenbakken) and Smedetoften.